The clinical efficacy of inhalation therapy for respiratory infection

Abstract

The clinical efficacy of inhalation therapy has been established against patients with bronchial asthma. Recently the inhalation of antimicrobial agents for respiratory infection is needed because few newer antibiotics have been developed.
The administration of inhaled of aminoglycoside antibiotic in patients with chronic respiratory pseudomonas aeruginosa infection indicated clinical efficacy. The usefulness of aerolized liposomal amphotericin B against patients with invasive pulmonary aspergillosis is expected.